FIELD: chemistry.
SUBSTANCE: present invention relates to novel dibenzosuberone derivatives of formula 
, where R1 and R2 each independently represent hydrogen or halogen. These compounds are used for treating and/or preventing diseases related to CB1 receptor modulation. The invention also relates to a pharmaceutical composition based on these compounds.
EFFECT: obtaining novel dibenzosuberone derivatives.
5 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL SPIROPENTACYCLIC COMPOUNDS | 2005 |
|
RU2360909C2 |
| APPLICATION OF DPP-IV INHIBITOR FOR REDUCTION OF GLYCEMIA ACUTE EXACERBATION | 2006 |
|
RU2440143C2 |
| CB1 RECEPTOR ANTAGONISTS | 2012 |
|
RU2593751C2 |
| USE OF RKS INHIBITORS IN DIABETES RELATED COMPLICATIONS | 2007 |
|
RU2447892C2 |
| 2-AMINOBENZOTHIAZOLS AS INVERS AGONIST OF CB RECEPTORS | 2004 |
|
RU2344132C2 |
| METHOD FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE CASES | 2002 |
|
RU2280443C2 |
| APPLICATION OF CB1 RECEPTOR ANTAGONISTS FOR PREPARATION OF COMPOSITION APPLICABLE FOR TREATMENT OF HEPATIC DISEASES | 2005 |
|
RU2402328C2 |
| IMIDAZOLINE DERIVATIVES HAVING CB-ANTAGONIST ACTIVITY | 2005 |
|
RU2357958C2 |
| 5-(3,4-DICHLOROPHENYL)-N-(2-HYDROXYCYCLOHEXYL)-6-(2,2,2-TRIFLUOROETHOXY)NICOTINAMIDE AND ITS SALT AS AGENTS INCREASING HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION | 2010 |
|
RU2541475C2 |
| COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ADDICTIONS | 2008 |
|
RU2492858C2 |
